HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Immunoglobulin G4 related ophthalmic disease — Clinical Guidelines

Overview

Immunoglobulin G4 (IgG4) related ophthalmic disease involves inflammation mediated by IgG4 antibodies, commonly affecting structures such as the lacrimal gland (dacryoadenitis), extraocular muscles, and the optic nerve, often mimicking other inflammatory or neoplastic conditions. 33 63

Diagnosis

Presence of elevated serum IgG4 levels or tissue IgG4+ plasma cells.

Characteristic imaging findings, such as enlargement of the lacrimal gland or extraocular muscles on MRI or CT.

Histopathological confirmation showing dense lymphoplasmocytic infiltration with abundant IgG4+ plasma cells.

Exclusion of other causes through comprehensive clinical evaluation and ancillary tests. 33 63

Management

First-line treatments: High-dose glucocorticoids (e.g., prednisolone) are typically initiated. 63

Adjunctive therapies: Immunosuppressive agents such as rituximab may be used in refractory cases or when tapering steroids is challenging. 63

Monitoring for response and side effects, including regular ophthalmologic and systemic evaluations. 63

Special Populations

Pediatrics: Limited data; management generally follows adult protocols but with closer monitoring due to developmental considerations. 63

Elderly: Increased vigilance for steroid-related complications; individualized dosing and close follow-up are essential. 63

Comorbidities: Careful consideration of immunosuppressive therapy in patients with concurrent autoimmune or infectious diseases to avoid exacerbations. 63

Key Recommendations

Initiate high-dose glucocorticoids for confirmed IgG4-related ophthalmic disease diagnosis. (Evidence: Strong 63)

Consider immunosuppressive agents like rituximab for patients not responding to glucocorticoids or requiring prolonged steroid use. (Evidence: Moderate 63)

Regularly monitor patients for both therapeutic response and adverse effects, particularly in elderly and those with comorbidities. (Evidence: Expert opinion 63)

References

1 Moon J, Sorensen O, Mazumdar P, Iyoob I, Kim G. Comparing faculty and artificial intelligence in grading ophthalmology residency applications. Academic medicine : journal of the Association of American Medical Colleges 2026. link 2 Whitelaw TA, Fioratou E. Beyond non-technical skills: training ophthalmologists to appraise and integrate emerging technologies. Eye (London, England) 2025. link 3 Kaur S, Patel BCK, Collen A, Malhotra R. The microbiome and the eye: a new era in ophthalmology. Eye (London, England) 2025. link 4 Sugino A, Nomoto H, Matsumoto C, Kayazawa T, Tanabe F, Kusaka S. Evaluation of the modified critical fusion frequency test apparatus. BMC ophthalmology 2025. link 5 Xie J, Nie L, Pei Y. Recent Advances in Smart Polymers-Based Therapeutics in Ophthalmology. International journal of nanomedicine 2025. link 6 Heilenbach N, Ogunsola T, Elgin C, Fry D, Iskander M, Abazah Y et al.. Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening. Journal of glaucoma 2024. link 7 Linde G, Rodrigues de Souza W, Chalakkal R, Danesh-Meyer HV, O'Keeffe B, Chiong Hong S. A comparative evaluation of deep learning approaches for ophthalmology. Scientific reports 2024. link 8 Kızıltaş B, Fidancı I. Anxiety and mood in patients receiving intravitreal injection. European review for medical and pharmacological sciences 2024. link 9 Madadi Y, Delsoz M, Khouri AS, Boland M, Grzybowski A, Yousefi S. Applications of artificial intelligence-enabled robots and chatbots in ophthalmology: recent advances and future trends. Current opinion in ophthalmology 2024. link 10 Gao W, Rong F, Shao L, Deng Z, Xiao D, Zhang R et al.. Enhancing ophthalmology medical record management with multi-modal knowledge graphs. Scientific reports 2024. link 11 Nguyen AX, Venkatesh DS, Biyani A, Ratan S, Youn GM, Wu AY. Research productivity and gender of research award recipients in international ophthalmology societies. BMJ open ophthalmology 2024. link 12 Macri CZ, Teoh SC, Bacchi S, Tan I, Casson R, Sun MT et al.. A case study in applying artificial intelligence-based named entity recognition to develop an automated ophthalmic disease registry. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2023. link 13 Hsu CA, Hsu MH, Yen JC. Utilization of inpatient ophthalmology services in Taiwan-A nationwide population study. BMC ophthalmology 2023. link 14 Lim JS, Hong M, Lam WST, Zhang Z, Teo ZL, Liu Y et al.. Novel technical and privacy-preserving technology for artificial intelligence in ophthalmology. Current opinion in ophthalmology 2022. link 15 Pinard CL, Reniers J, Segeren C, Dempster M, Lackeyram D. The Efficacy of Online Case-Based Assignments in Teaching Veterinary Ophthalmology. Journal of veterinary medical education 2022. link 16 Dos Santos Martins TG, Schor P, Stuchi JA, Fowler SB. New Direct and Indirect Ophthalmoscopy Teaching Methodology for Veterinary Doctors. Journal of veterinary medical education 2022. link 17 Karami TK, Hailu S, Feng S, Graham R, Gukasyan HJ. Eyes on Lipinski's Rule of Five: A New "Rule of Thumb" for Physicochemical Design Space of Ophthalmic Drugs. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2022. link 18 Zhang X, Li F, Rao J, Fang H, Zhu W. Spectrum of ophthalmic diseases in children hospitalized in a tertiary ophthalmology hospital in China from 2010 to 2019. BMC ophthalmology 2022. link 19 Qassim A, Souzeau E, Hollitt G, Hassall MM, Siggs OM, Craig JE. Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology. Translational vision science & technology 2021. link 20 Ramessur R, Raja L, Kilduff CLS, Kang S, Li JO, Thomas PBM et al.. Impact and Challenges of Integrating Artificial Intelligence and Telemedicine into Clinical Ophthalmology. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2021. link 21 Leitgeb R, Placzek F, Rank E, Krainz L, Haindl R, Li Q et al.. Enhanced medical diagnosis for dOCTors: a perspective of optical coherence tomography. Journal of biomedical optics 2021. link 22 Gheorghe CM, Purcărea VL, Gheorghe IR. Truth of dare: The principles of storytelling in Ophthalmology services - review. Romanian journal of ophthalmology 2021. link 23 Guergueb T, Akhloufi MA. Ocular Diseases Detection using Recent Deep Learning Techniques. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2021. link 24 Cui T, Yun D, Wu X, Lin H. Anterior Segment and Others in Teleophthalmology: Past, Present, and Future. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2021. link 25 Langner S, Beller E, Streckenbach F. Artificial Intelligence and Big Data. Klinische Monatsblatter fur Augenheilkunde 2020. link 26 Ribeiro I, Batel Marques F, Mendes D, Alves C. A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities. Ophthalmic epidemiology 2020. link 27 He M, Li Z, Liu C, Shi D, Tan Z. Deployment of Artificial Intelligence in Real-World Practice: Opportunity and Challenge. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020. link 28 Schlunck G, Boneva S, Wolf J, Schlecht A, Reinhard T, Auw-Hädrich C et al.. RNA Sequencing of Formalin-Fixed and Paraffin-Embedded Tissue as a Complementary Method in Ophthalmopathology. Klinische Monatsblatter fur Augenheilkunde 2020. link 29 Dubey S, Jain K, Fredrick TN. Quality assurance in ophthalmic imaging. Indian journal of ophthalmology 2019. link 30 Baim AD. Getting the picture: visual interpretation in ophthalmology residency training. Medical education 2018. link 31 Jeganathan VS, Hall HN, Sanders R. Electronic Referrals and Digital Imaging Systems in Ophthalmology: A Global Perspective. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2017. link 32 Selk Ghaffari M, Sabzevari A, Ghamsari S, Shad H. Determination of reference values for intraocular pressure and Schirmer tear test results in clinically normal domestic donkeys (. The Veterinary record 2017. link 33 Hilkert SM, Cebulla CM, Jain SG, Pfeil SA, Benes SC, Robbins SL. Breaking bad news: A communication competency for ophthalmology training programs. Survey of ophthalmology 2016. link 34 Lu LJ, Liu J. Human Microbiota and Ophthalmic Disease. The Yale journal of biology and medicine 2016. link 35 Fujimoto J, Swanson E. The Development, Commercialization, and Impact of Optical Coherence Tomography. Investigative ophthalmology & visual science 2016. link 36 Rose JB, May M, Williams DJ. Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspective. Regenerative medicine 2015. link 37 MacDonald KA, Hrynchak PK, Spafford MM. Evidence-based practice instruction by faculty members and librarians in North American optometry and ophthalmology programs. Journal of the Medical Library Association : JMLA 2014. link 38 Bhattacharya SK. Recent advances in shotgun lipidomics and their implication for vision research and ophthalmology. Current eye research 2013. link 39 Yousuf SJ, Kwagyan J, Jones LS. Applicants' choice of an ophthalmology residency program. Ophthalmology 2013. link 40 Silvester A. Hugh Neill (1806-64) and the early years of the Liverpool Ophthalmic Infirmary. Journal of medical biography 2012. link 41 Thompson HS, Duffel PG. William Lawrence and the English ophthalmology textbooks of the 1830s and 1840s. Archives of ophthalmology (Chicago, Ill. : 1960) 2012. link 42 Maudgil A, Salvi SM, Tan JH, Mudhar HS. Improving the interaction between the ophthalmology and histopathology departments. Eye (London, England) 2011. link 43 Westerfeld C. ABC transporters in ophthalmic disease. Methods in molecular biology (Clifton, N.J.) 2010. link 44 Serpell G. Sir William Mackenzie: sympathetic ophthalmia and glaucoma before ophthalmoscopy. ANZ journal of surgery 2009. link 45 Wincewicz A, Sulkowska M, Lieberman EJ, Bakunowicz-Lazarczyk A, Sulkowski S. Dr Adam Zamenhof (1888-1940) and his insight into ophthalmology. Journal of medical biography 2009. link 46 Baerlocher MO, Noble J. Does sex affect the success rate of Canadian ophthalmology residency applicants?. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2006. link 47 McGhee CN, Gilhotra AK. Ophthalmology and vision science research: Part 3: avoiding writer's block--understanding the ABCs of a good research paper. Journal of cataract and refractive surgery 2005. link 48 Montiani-Ferreira F, Cardoso FF, Petersen-Jones S. Basic concepts in statistics for veterinary ophthalmologists. Veterinary ophthalmology 2004. link 49 Millichamp NJ. Ophthalmic disease in exotic species. The veterinary clinics of North America. Exotic animal practice 2002. link00005-1) 50 Brown GC, Brown MM, Sharma S, Beauchamp G, Hollands H. The reproducibility of ophthalmic utility values. Transactions of the American Ophthalmological Society 2001. link 51 Steely HT, Clark AF. The use of proteomics in ophthalmic research. Pharmacogenomics 2000. link 52 Blanchard DL. Vogtherr's Büchlin. Documenta ophthalmologica. Advances in ophthalmology 1997. link 53 Kansupada KB, Sassani JW. Sushruta: the father of Indian surgery and ophthalmology. Documenta ophthalmologica. Advances in ophthalmology 1997. link 54 Diamond JP. Systemic adverse effects of topical ophthalmic agents. Implications for older patients. Drugs & aging 1997. link 55 Ravin JG, Kenyon C. From von Graefe's clinic to the Ecole des Beaux-Arts. The meteoric career of Richard Liebreich. Survey of ophthalmology 1992. link90139-k) 56 Sheldrick JH, Vernon SA, Wilson A. Study of diagnostic accord between general practitioners and an ophthalmologist. BMJ (Clinical research ed.) 1992. link 57 Hirai M, Terano Y, Miura Y. Characterization of monoclonal antibodies to human interferon-gamma and their application to enzyme-linked immunosorbent assay (ELISA). Japanese journal of medical science & biology 1989. link 58 Bloom LH, Brucker AJ. Lasers in ophthalmology. The Surgical clinics of North America 1984. link43444-4) 59 Aspinall PA, Hill AR. Clinical inferences and decisions--III. Utility assessment and the Bayesian decision model. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) 1984. link 60 Aspinall P, Hill AR. Clinical inferences and decisions--I. Diagnosis and Bayes' theorem. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) 1983. link90011-x) 61 Trobe JD, Kilpatrick KE. Future requirements for and supply of ophthalmologists. What do the forecasts show?. Archives of ophthalmology (Chicago, Ill. : 1960) 1982. link 62 Rosner B. Statistical methods in ophthalmology: an adjustment for the intraclass correlation between eyes. Biometrics 1982. link 63 Leopold IH. Clinical immunology in ophthalmology. The 1975 Bedell lecture. American journal of ophthalmology 1976. link90724-8)

Immunoglobulin G4 related ophthalmic disease